Castleview Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Castleview Partners's PFE Position: Q1 2026 in Review
Castleview Partners increased its Pfizer (PFE) stake by 21% in Q1 2026, buying an estimated $73.7K and bringing the position to 16,262 shares worth $457K. The position accounts for 0.23% of the portfolio, ranked #103.
Castleview Partners first reported a position in PFE in Q1 2018 and has held it in 20 quarters since. The position peaked at $844K in Q1 2022. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Castleview Partners held 16,262 shares of Pfizer worth $457K as of Q1 2026.
- Castleview Partners bought 2,767 Pfizer shares in Q1 2026, an estimated $73.7K.
- Pfizer made up 0.23% of Castleview Partners's portfolio in Q1 2026, its #103 holding.
- Castleview Partners first reported a position in Pfizer in Q1 2018 and has held it in 20 quarters since.
- Castleview Partners's Pfizer position peaked at $844K in Q1 2022.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Castleview Partners's 13F filing for Q1 2026, filed 1 May 2026.